Showing results 1 to 5 of 5
Title | Author(s) | Issue Date | |
---|---|---|---|
Allopurinol reduces cardiac keap1 and activates NrF2/p62 to attenuate diabetic cardiomyopathy Proceeding/Conference:Circulation | 2018 | ||
Allopurinol Reduces Oxidative Stress and Activates Nrf2/p62 to Attenuate Diabetic Cardiomyopathy in Rats Journal:Journal of Cellular and Molecular Medicine | 2020 | ||
FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes Journal:Journal of Cellular and Molecular Medicine | 2020 | ||
Pharmacologic Inhibition of FOXO1 Improves Cardiac Function by Enhancing Glucose Metabolism and Attenuating Apoptosis in Type-1 Diabetic Rats Proceeding/Conference:The FASEB Journal | 2018 | ||
Up-regulation of FoxO1 contributes to adverse vascular remodelling in type 1 diabetic rats Journal:Journal of Cellular and Molecular Medicine | 2020 |